Advancing to IND-enabling studies with multiple drug candidates Enveric’s Growing Patent Portfolio Validated CAMBRIDGE, Mass. (BUSINESS WIRE) Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspire.